REQUEST A DEMO
Total
USD $0.00
Search more companies

Central De Patologia Del Cesar Limitada (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Ambulatory Health Care Services
Full name: Central De Patologia Del Cesar Limitada Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Central De Patologia Del Cesar Limitada is a company based in Colombia, with its head office in Valledupar. The company operates in the Diagnostic Imaging Centers sector. It was incorporated on May 03, 2000. There are currently 14 (2017) people employed by Central De Patologia Del Cesar Limitada. In its most recent financial highlights, the company reported a net sales revenue increase of 8.57% in 2025. Its’ total assets recorded a growth of 24.96%. The net profit margin of Central De Patologia Del Cesar Limitada increased by 5.46% in 2025.

Headquarters
Cl 14 11A 02
Valledupar; Cesar;

Contact Details: Purchase the Central De Patologia Del Cesar Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Central De Patologia Del Cesar Limitada report to view the information.
Registered Capital:
Purchase the Central De Patologia Del Cesar Limitada report to view the information.
Financial Auditors:
Purchase the Central De Patologia Del Cesar Limitada report to view the information.
Incorporation Date:
May 03, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Central De Patologia Del Cesar Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
8.57%
Total Operating Revenue
8.57%
Operating Profit
48.62%
EBITDA
48.19%
Net Profit/Loss for the Period
39.92%
Total Assets
24.96%
Total Equity
27.19%
Operating Profit Margin
6.66%
Net Profit Margin
5.46%
Return on Equity (ROE)
2.59%
Quick Ratio
1.33%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?